TCL Archive The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year April 20, 2012
TCL Archive Large Studies Show Promising Results For Targeted Therapies Alimta, Tarceva June 26, 2009
TCL Archive Safety Concerns About Saltz Regimen Were Statistical Artifact, ODAC Finds. December 14, 2001
